Karnataka

Intra Labs is involved in the manufacturing and marketing of Pharameceutical Formulations - Therapeutic and Prophylactic since 1981  We have GMP accredited and manufacturing facility specialities patented in accordance with WHO norms.  Our Company has a wide range of Marketing Network throughout the country to cadre with easy accessibility to our clients.  Intra labs Sciences has chosen the path of providing truly world class quality products at affordable prices to contribute significantly towards this t

Applications are invited on plain paper for the following purely temporary contractual posts ICMR Task Force Project entitled “National Hospital Based Rotavirus Surveillance Network” at Regional Medical Research Centre, Belgaum.

Post: Scientist B (Non medical: Microbiologist) – One post

[adsense:336x280:8701650588]

About Authors:
Nareshkumar. G¹*, A.Eashwar rao², Ch.Ganga prasad³.
¹*Center for Pharmaceutical Sciences, IST, JNTU Hyderabad, India,
²Talla Padmavathi College of Pharmacy, Warangal, India,
³National College of Pharmacy, Shimoga, Karnataka, India.
*nareshkumar62@gmail.com

ABSTRACT:
Liquisolid technique is a new and propitious method that can change the dissolution rate of poorly water soluble drugs. According to the new formulation method of liquisolid compacts, liquid medications such as solutions or suspensions of water insoluble drugs in suitable non-volatile liquid vehicles can be converted into acceptably flowing and compressible powders by blending with selected powder excipients. It has been speculated that such systems exhibit enhanced release profiles. In this case, even though the drug is in a solid dosage form, it is held within the powder substrate in solution or, in a solubilized, almost molecularly dispersed state, which contributes to the enhanced drug dissolution properties. Successful liquisolid tablet is a determination of optimal flowable liquid retention.

[adsense:336x280:8701650588]

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.